Article Details

Biocytogen Signs RenMab™/RenLite™ Licensing Agreement with BeiGene - PR Newswire

Retrieved on: 2022-04-25 20:18:51

Tags for this article:

Click the tags to see associated articles and topics

Biocytogen Signs RenMab™/RenLite™ Licensing Agreement with BeiGene - PR Newswire. View article details on hiswai:

Excerpt

Meanwhile, RenLite™ mice can generate bispecific antibodies with simple monoclonal antibody structures, reducing the difficulty of subsequent drug ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up